NeuroBlateEdX – Monteris Physician Microsite

At Monteris, we’re committed to offering education and training materials to help you deliver the best care possible. And, on your schedule. Content is designed for physicians looking to advance their knowledge and skill sets in the use of laser interstitial thermal therapy (LITT) for epilepsy, brain tumors, and radiation necrosis.

BRAIN
TUMORS

EPILEPSY

FEATURED LEARNING

2024 AANS Panel Discussion

Driving the Science of MR-guided Laser Ablation: New Frontiers in Hyperthermic Research and Applications in Brain Tumors and Focal Epilepsy

Presenters: Albert Kim, MD; Matthew Smyth, MD, FACS, FAAP; Orin Bloch, MD

Evidence for LITT and Blood-Brain Barrier Disruption

Breaking Barriers: The Evidence for Hyperthermia’s Therapeutic Disruption of the Blood Brain Barrier and the Outlook on Immune Benefits in the Brain

Presenter: Albert Kim, MD

Post-SRS progression, the importance of early intervention, and what the evidence tells us

See this important discussion on the challenges and opportunities for patients with radiographic progressive disease, including a look at the tools and evidence available to practitioners to address specific patient needs. This program also includes a review of the latest prospective outcomes documenting the efficacy of laser interstitial thermal therapy (LITT) for biopsy proven radiation necrosis, the value of early biopsy for these patients, and where LITT fits in the treatment spectrum.

Presenters: Roy Strowd III, MD; Michael Chan, MD; Adrian Laxton, MD

Evidence on LITT for pure IDH Wild-type glioblastoma cohort and more

Exciting new data on LITT for large cohort of pure IDH Wild–type glioblastoma, and a preview of promising studies on LITT and BBB disruption.

Presenter: John de Groot, MD

Laser Ablation and the Oncology Patient: New Evidence, What’s Coming and What You Need to Know

Discussion of LITT indications, uses and experiences in oncology.

Presenters: Peter E. Fecci, MD, PhD; John de Groot, MD; Roy Strowd III, MD

Stereotactic Laser Ablation in Neuro-oncology

Discussion of the rationale and principals of laser interstitial thermal therapy (LITT).

Presenter: Clark Chen, MD, PhD

LITT Bibliography

Establishing an MR-Guided Laser Ablation Program

Discussion on the role of Laser Interstitial Thermal Therapy (LITT) in one group’s practice.

Presenters: Ian Lee, MD; James Snyder, DO

Updates on Laser Ablation in Neuro-Oncology – Efficacy of LITT for newly diagnosed and recurrent IDH wild-type glioblastoma

Discussion on LITT hospitalization, utilization and key outcomes of the recent prospective multi-center publication on the largest cohort to date of LITT for IDH wild-type glioblastoma. Clinical data updates for LITT in Mets and typical LITT case reviews.

Presenter: John de Groot, MD

LITT-Cast: NeuroBlate and the Steroid-Dependent Patient

Neurosurgeons Saadi Ghatan, MD of Mount Sinai Health System, Steven Abram, MD of Ascension Saint Thomas, and Peter Fecci, MD, PhD of the Duke University School of Medicine, discuss their experiences with NeuroBlate® and steroid-dependent patients.

Presenters: Peter E. Fecci, MD, PhD; Steven Abram, MD; Saadi Ghatan, MD

LITT-Cast: The Role of Avastin

Peter Fecci, MD, PhD, neurosurgeon at the Duke University School of Medicine, discusses his experience regarding the role of Avastin with recurrent GBM, radiation necrosis, and LITT.

Presenter: Peter E. Fecci, MD, PhD

Optimizing the Management of Recurrent Metastatic Brain Tumors: A Multi-Disciplinary Approach

Multi-disciplinary panelists share their experiences using LITT to manage recurrent metastatic brain tumors.

Presenters: Roy Strowd III, MD; Michael Chan, MD; Adrian Laxton, MD